Design of randomized controlled trials to estimate cancer-mortality reductions from multicancer detection screening

Determining whether screening with multicancer detection (MCD) tests saves lives requires randomized controlled trials (RCTs). To inform RCT design, we estimated cancer-mortality outcomes from hypothetical MCD RCTs.